S2k guidelines for the use of topical preparations on the skin

J Dtsch Dermatol Ges. 2018 Mar;16(3):376-392. doi: 10.1111/ddg.13473.

Abstract

The present guidelines are aimed at dermatology residents and board-certified dermatologists as well as policymakers and insurance companies. Developed by dermatologists in collaboration with pharmacists using a formal consensus process (S2k), they include general aspects with respect to pharmacokinetics and regulatory terminology. Recommendations are provided on the various indications for extemporaneous preparations and their quality assurance. The importance of pharmaceutical vehicles and problems associated with substituting one vehicle for another are discussed. The guidelines include criteria for choosing a suitable pharmaceutical vehicle and for specific aspects in terms of treatment planning. In addition, recommendations are given for managing allergic reactions to vehicles or additives.

MeSH terms

  • Consensus
  • Dermatologic Agents / administration & dosage*
  • Dermatologic Agents / adverse effects
  • Dermatologic Agents / classification
  • Dermatologic Agents / pharmacokinetics
  • Dermatology / education
  • Drug Compounding
  • Drug Eruptions / etiology
  • Drug Eruptions / therapy
  • Germany
  • Humans
  • Internship and Residency
  • Pharmaceutical Vehicles / adverse effects
  • Quality Assurance, Health Care
  • Risk Factors
  • Skin Diseases / drug therapy*
  • Terminology as Topic

Substances

  • Dermatologic Agents
  • Pharmaceutical Vehicles